Explore the Synergy of Combination TKI Therapy

NCT02129166 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI resigned

Conditions

Healthy Volunteers

Interventions

DRUG: Dasatinib
DRUG: Dasatinib+Imatinib

Sponsor

University of Florida